RAPT Therapeutics Inc (RAPT)
4.03
-0.11
(-2.66%)
USD |
NASDAQ |
May 17, 16:00
4.03
0.00 (0.00%)
After-Hours: 18:59
RAPT Therapeutics Enterprise Value: 2.922M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.922M |
| May 15, 2024 | 6.586M |
| May 14, 2024 | -1.965M |
| May 13, 2024 | 12.00M |
| May 10, 2024 | 9.553M |
| May 09, 2024 | 21.07M |
| May 08, 2024 | 136.95M |
| May 07, 2024 | 140.44M |
| May 06, 2024 | 147.42M |
| May 03, 2024 | 149.17M |
| May 02, 2024 | 142.01M |
| May 01, 2024 | 143.93M |
| April 30, 2024 | 127.18M |
| April 29, 2024 | 133.46M |
| April 26, 2024 | 141.14M |
| April 25, 2024 | 130.67M |
| April 24, 2024 | 134.16M |
| April 23, 2024 | 137.65M |
| April 22, 2024 | 132.76M |
| April 19, 2024 | 135.90M |
| April 18, 2024 | 135.21M |
| April 17, 2024 | 139.05M |
| April 16, 2024 | 142.19M |
| April 15, 2024 | 156.50M |
| April 12, 2024 | 179.18M |
| Date | Value |
|---|---|
| April 11, 2024 | 185.82M |
| April 10, 2024 | 173.25M |
| April 09, 2024 | 153.01M |
| April 08, 2024 | 148.82M |
| April 05, 2024 | 134.16M |
| April 04, 2024 | 138.00M |
| April 03, 2024 | 150.21M |
| April 02, 2024 | 144.98M |
| April 01, 2024 | 153.36M |
| March 28, 2024 | 153.64M |
| March 27, 2024 | 151.88M |
| March 26, 2024 | 133.44M |
| March 25, 2024 | 128.92M |
| March 22, 2024 | 131.00M |
| March 21, 2024 | 137.27M |
| March 20, 2024 | 143.18M |
| March 19, 2024 | 141.79M |
| March 18, 2024 | 131.00M |
| March 15, 2024 | 135.87M |
| March 14, 2024 | 133.79M |
| March 13, 2024 | 139.70M |
| March 12, 2024 | 118.48M |
| March 11, 2024 | 123.00M |
| March 08, 2024 | 157.10M |
| March 07, 2024 | 164.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.965M
Minimum
May 14 2024
999.05M
Maximum
Jan 06 2022
488.82M
Average
455.37M
Median
Sep 20 2023
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.104B |
| Avinger Inc | 15.35M |
| Tonix Pharmaceuticals Holding Corp | 1.314M |
| Skye Bioscience Inc | 265.10M |
| Axsome Therapeutics Inc | 3.521B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.52M |
| Total Expenses (Quarterly) | 32.52M |
| EPS Diluted (Quarterly) | -0.79 |
| Earnings Yield | -76.43% |
| Normalized Earnings Yield | -63.28 |